esmo 2018 industry satellite symposium treating …€¦ · expert faculty panel, leads a live,...

1
MONDAY, 22 OCTOBER, 2018 CME SYMPOSIUM: 18:30 - 20:00 VENUE: MESSE MUNICH, MUNICH, GERMANY ROOM: HALL B4 – ROOM 19 CHAIR Rupert M. Bauersachs, MD Professor of Internal Medicine Director, Department of Vascular Medicine Klinikum Darmstadt GmbH Darmstadt, Germany Supported by Bayer AG Treating Cancer-Associated Thrombosis Today New Concepts and Perspectives CME Rupert M. Bauersachs, MD, along with an expert faculty panel, leads a live, interactive CME symposium on cancer and thrombosis (CAT), including the latest data, relevant case studies, and implications for clinical care. ESMO 2018 INDUSTRY SATELLITE SYMPOSIUM TARGET AUDIENCE This activity is intended for oncologists, hematologists, cardiologists, primary care physicians, and other healthcare professionals who treat patients with venous thromboembolism (VTE) and cancer. LEARNING OBJECTIVES Upon completion of this activity, participants will: Have increased knowledge regarding the • Burden of thrombosis in patients with cancer • Latest guideline-recommended approaches for treatment of VTE in patients with cancer • Latest registry and real-world data on the use of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with cancer and VTE Have greater competence related to • Use of effective strategies to treat VTE in patients with cancer ACCREDITATION STATEMENT In support improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. For Physicians Medscape, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. AGENDA 18:30 - 18:35 Welcome and Introductions Rupert M. Bauersachs, MD 18:35 - 18:50 VTE and Cancer: Current Treatment Approaches and Challenges Alexander T. Cohen, MD, FRACP 18:50 - 19:05 Cancer-Associated Thrombosis (CAT): Updates and Implications for Clinical Care Marc Carrier, MD, MSc, FRCPC 19:05 - 19:20 NOACs in CAT: Exploring the Latest Data Rupert M. Bauersachs, MD 19:20 - 19:35 Challenging Cases of CAT: How to Treat? Anthony Maraveyas, MD, FRCP, PhD 19:35 - 20:00 Panel Discussion and Q & A Rupert M. Bauersachs, MD Refreshments offered by Medscape

Upload: others

Post on 28-Oct-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: ESMO 2018 INDUSTRY SATELLITE SYMPOSIUM Treating …€¦ · expert faculty panel, leads a live, interactive CME symposium on cancer and thrombosis (CAT), including the latest data,

MONDAY, 22 OCTOBER, 2018CME SYMPOSIUM: 18:30 - 20:00

VENUE: MESSE MUNICH, MUNICH, GERMANYROOM: HALL B4 – ROOM 19

CHAIRRupert M. Bauersachs, MDProfessor of Internal MedicineDirector, Department of Vascular MedicineKlinikum Darmstadt GmbHDarmstadt, Germany

Supported by Bayer AG

Treating Cancer-AssociatedThrombosis Today New Concepts and Perspectives CME

Rupert M. Bauersachs, MD, along with an expert faculty panel, leads a live, interactive CME symposium on cancer and thrombosis (CAT), including the latest data, relevant case studies, and implications for clinical care.

ESMO 2018 INDUSTRY SATELLITE SYMPOSIUM

TARGET AUDIENCEThis activity is intended for oncologists, hematologists, cardiologists, primary care physicians, and other healthcare professionals who treat patients with venous thromboembolism (VTE) and cancer.

LEARNING OBJECTIVESUpon completion of this activity, participants will:

Have increased knowledge regarding the • Burden of thrombosis in patients with cancer

• Latest guideline-recommended approaches for treatment of VTE in patients with cancer

• Latest registry and real-world data on the use of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with cancer and VTE

Have greater competence related to

• Use of effective strategies to treat VTE in patients with cancer

ACCREDITATION STATEMENTIn support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For PhysiciansMedscape, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AGENDA

18:30 - 18:35Welcome and Introductions Rupert M. Bauersachs, MD

18:35 - 18:50VTE and Cancer: Current Treatment Approaches and Challenges Alexander T. Cohen, MD, FRACP

18:50 - 19:05Cancer-Associated Thrombosis (CAT): Updates and Implications for Clinical Care Marc Carrier, MD, MSc, FRCPC

19:05 - 19:20NOACs in CAT: Exploring the Latest Data Rupert M. Bauersachs, MD

19:20 - 19:35Challenging Cases of CAT: How to Treat? Anthony Maraveyas, MD, FRCP, PhD

19:35 - 20:00Panel Discussion and Q & A Rupert M. Bauersachs, MD

Refreshments offered by Medscape